Fujisawa Pharmaceutical Company, Ltd.

Nidec Corporation

Masayuki Kato

Ikuo Ueda

Hisashi Takasugi

Kiyotaka Ito

Shigetaka Nishino

Masanobu Nagano

Atsushi Akahane

Teiji Kishimoto

Masaaki Matsuo

Kiyoshi Tsuji

Toshio Yamanaka

Youichi Shiokawa

Hiromu Kochi

Nobukiyo Konishi

Mitsuru Ohkubo

Fumie Takahashi

Mitsuko Hamano

Tomotsugu Sugiyama

Hideyuki Takemoto

Hiroyoshi Sakai

Masamune Hiraki

Takayuki Kinouchi

Guifeng Zhang

George Harlan

Yoshiharu Kasai

Yosiharu Kasai

A motor device includes motors, detector in the respective motors to detect motor rotational speeds, and an output controller configured or programmed to output a single output rotational speed based on the motor rotational speeds input from the detectors. The output controller multiplies at least one of the input motor rotational speeds by a coefficient derived based on target rotational speeds of the motors to calculate a conversion value, and determines the output rotational speed.

Motor device, blowing device, and server device

A fan system includes a pulse signal generation portion and a plurality of fans. Each of the plurality of fans preferably includes a motor portion; an impeller arranged to be rotated by the motor portion; a drive circuit arranged to drive the motor portion; a rotation detection portion arranged to detect rotation of the motor portion; and a rotation rate control circuit arranged to, based on a reference pulse signal supplied from the pulse signal generation portion and an actual rotation pulse signal supplied from the rotation detection portion, exercise feedback control on a rotation rate of the motor portion in accordance with a period of the reference pulse signal.

Fan system and electronic device

&bgr;-alanine compounds or a pharmaceutically acceptable salt thereof, which is useful as a glycoprotein IIB/IIIa antagonist, inhibitor of blood platelet aggregation and inhibitor of the binding of fibrinogen to blood platelet; a composition containing the same, a process for the preparation of the compound, and a process for the treatment of diseases caused by thrombus formation, for example, are provided.

N-acylpiperidinylcarbonylaminocarboxylic acids and their use as glycoprotein IIb/IIIa antagonists and fibrinogen-blood platelets binding inhibitors

Beta-alanine derivative and a process for the preparation thereof

A new nitro compound of the formula: ##STR1## wherein R.sup.1 and R.sup.2 are each lower alkyl or lower alkoxy(lower)-alkyl, or ##STR2## is cyclized to form ##STR3## X is --O--, --S-- or --NH--, m is an integer 0 or 1, and

Nitro compounds, process for preparation thereof and use thereof

The invention relates to a method of treating cardiac ischemic disease using a compound of the formula: ##STR1## wherein R.sup.1 is hydrogen, lower alkyl, lower alkenyl or N,N-di(lower)alkylaminomethyl,

Therapeutic agent for ischemic diseases

The present invention relates to novel pyrimidoindole derivatives and pharmaceutically acceptable salts thereof, in particular (+)-3,4-dihydro-5-methyl-2-[1-(5-methyl-1H-imidazol-4-yl)ethyl]pyrimido-[1 ,6-a]indol-1(2H)-one or its hydrochloride, useful for their 5-hydroxytryptamine antagonism.

Pyrimidoindole derivatives and processes for preparation thereof

A compound of the formula: ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 are each hydrogen, lower alkyl, lower alkenyl, aryl or ar(lower)alkyl,

The invention relates to compounds for treatment of nausea and vomiting, of the formula ##STR1## wherein R.sup.1 is hydrogen, lower alkyl, lower alkenyl or N,N-di(lower)alkylaminomethyl,

Pyridoindole derivatives and processes for preparation thereof

Compounds of the formula: ##STR1## wherein R.sup.1 is hydrogen, lower alkyl or lower alkenyl, R.sup.2 is hydrogen, lower alkyl, or halogen, R.sup.3 is imidazolyl or pyridyl, each of which may have suitable substituents, and R.sup.4 is hydrogen, lower alkyl, lower alkenyl or hydroxy (lower) alkyl and R.sup.5 is hydrogen, hydroxy, or alkanoyloxy, or R.sup.4 and R.sup.5 are linked together to form an additional bond or novel pyridoindole derivatives which are useful as potent in selective antagonists of 5-HT receptors.

This invention relates to new 2(1H)-quinolinone compounds having the formula: ##STR1## wherein R.sup.1 is a imidazopyridyl, thiazolyl, indolyl, dihydroindolyl, imidazolyl, benzimidazolyl, quinolyl, isoquinolyl, quinazolinyl, dihydroisoquinolyl, tetrahydroimidazopyridyl or tetrahydroquinolyl, each of which may be substituted with substituents(s) selected from the group consisting of lower alkyl, halogen, lower alkoxy, lower alkylthio, ar(lower)alkoxy, cyano, nitro, amino, lower alkylamino, acylamino, hydroxy and oxo,

2(1H)-quinolinone compounds and pharmaceutical composition comprising

A compound of the formula: ##STR1## wherein R.sup.1 is lower alkyl,

Imidazoisoquinoline compounds useful as anti-ulcerative agents

Anti-allergic quinazolinone derivatives are disclosed which have the formula ##STR1## wherein R.sup.3 is hydrogen or lower alkyl and A is lower alkylene.

Growing community of inventors

Kyoto, Japan

Masayuki Kato